Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

NCT00406458 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Diabetic Polyneuropathy

Interventions

DRUG: SB-509
OTHER: Normal Saline

Sponsor

Sangamo Therapeutics

Collaborators

[object Object]